Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 113,623	$ 503,281
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Investment income	(11,741)	(113,239)
Depreciation and amortization	583	579
Equity-based compensation	1,497	3,403
Net realized and unrealized gain from consolidated funds’ investments	(39,134)	(59,912)
Accretion of original issue and market discount of consolidated funds’ investments, net	(7,223)	842
Income distributions from corporate investments in funds and companies	10,898	70,497
SPAC deconsolidation gain and other non-cash items	0	(72,347)
Cash flows due to changes in operating assets and liabilities:
Net cash (used) provided in operating activities	(701,802)	66,657
Cash flows from investing activities:
Purchases of U.S. Treasury and other securities	(4,425)	(7,503)
Proceeds from maturities and sales of U.S. Treasury and other securities	0	7,503
Corporate investments in funds and companies	(21,922)	(74,391)
Distributions and proceeds from corporate investments in funds and companies	14,031	111,408
Purchases of fixed assets	(96)	(12)
Net cash (used) provided by investing activities	(12,412)	37,005
Cash flows from financing activities:
Net cash provided by financing activities	709,379	288,905
Effect of exchange rate changes on cash	3,686	(9,349)
Net (decrease) increase in cash and cash-equivalents	(1,149)	383,218
Initial consolidation (deconsolidation) of funds	0	(206,099)
Cash and cash-equivalents, beginning balance	1,159,119	1,200,341
Cash and cash-equivalents, ending balance	1,157,970	1,377,460
Total cash and cash-equivalents	1,157,970	1,377,460
Oaktree Capital Group Excluding Consolidated Funds
Cash flows due to changes in operating assets and liabilities:
Decrease in deferred tax assets	505	105
Decrease in other assets	4,942	559
(Increase) decrease in net due from affiliates	312,556	(13,319)
Increase (decrease) in accrued compensation expense	(105,324)	12,240
Decrease in accounts payable, accrued expenses and other liabilities	(3,145)	(4,996)
Cash flows from financing activities:
Capital contributions, net	111,211	35,517
Distributions to Class A unitholders	(94,964)	(105,584)
Distributions to OCGH unitholders	(54,703)	(65,671)
Distributions to preferred unitholders	(6,829)	(6,829)
Cash and cash-equivalents, ending balance	121,325	504,693
Total cash and cash-equivalents	121,325	504,693
Consolidated Funds
Cash flows due to changes in operating assets and liabilities:
Decrease in accounts payable, accrued expenses and other liabilities	(10,383)	18,490
Increase in dividends and interest receivable	(11,352)	(10,434)
Increase in due from brokers	(39,158)	(420)
Increase in receivables for securities sold	(44,608)	(38,668)
Decrease in other assets	12,401	40,333
Increase in payables for securities purchased	19,641	373,474
Purchases of securities	(3,092,034)	(2,108,475)
Proceeds from maturities and sales of securities	2,185,654	1,464,664
Cash flows from financing activities:
Contributions from non-controlling interests	533,419	256,391
Distributions to non-controlling interests	(89,928)	(22,582)
Proceeds from debt obligations issued by CLOs	528,876	83,205
Payment of debt issuance costs	(2,275)	(1,182)
Repayment on debt obligations issued by CLOs	(237,540)	(39,219)
Borrowings on credit facilities	242,749	154,859
Repayments on credit facilities	(220,637)	0
Cash and cash-equivalents, ending balance	1,036,645	872,767
Total cash and cash-equivalents	$ 1,036,645	$ 872,767